First-In-Human (Fih) Phase I Study Of A Selective Vegfr/Fgfr Dual Inhibitor Sulfatinib With Milled Formulation In Patients With Advanced Solid Tumors.

JOURNAL OF CLINICAL ONCOLOGY(2014)

引用 0|浏览9
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要